bims-meglyc
Biomed News
on Metabolic disorders affecting glycosylation
Issue of
2026–01–11
one paper selected by
Silvia Radenkovic
,
UMC Utrecht
Expanded characterization of glycosylation abnormalities and galactose therapy in a patient with CCDC115-CDG using semi-quantitative N-glycan analysis of total and fractionated plasma glycoproteins, in response to Geerts et al. [1].
Mol Genet Metab. 2025 Dec 23. pii: S1096-7192(25)00700-0. [Epub ahead of print]147(3): 109708
Expanded characterization of glycosylation abnormalities and galactose therapy in a patient with CCDC115-CDG using semi-quantitative N-glycan analysis of total and fractionated plasma glycoproteins, in response to Geerts et al. [1].
Yupeng Liu
,
Christina Lam
,
Sheri Poskanzer
,
Jenny Thies
,
Holly Stevens
,
Wenyue Zhang
,
Eva Morava
,
Miao He
.
Keywords:
CCDC115; Congenital disorders of glycosylation; Galactose therapy; N-glycan profile
DOI:
https://doi.org/10.1016/j.ymgme.2025.109708